Mylan Pharmaceuticals is splashed across news sites as it announces a partnership with Disney theme parks, to make park users more aware of stations set up for use of EpiPen epinephrine autoinjectors, for patrons experiencing severe allergic reactions.
Mylan also announced that it was expanding a program to provide the autoinjector pens, free of charge, to schools. Pennsylvania joined a number of states in the United States permitting (or, in some cases, requiring), public schools to stock epinephrine autoinjectors. California passed legislation in September requiring each school to have at least one autoinjector prescribed to the school or district, and to have at least one staff member trained in its use. Other states permit students to carry their own prescribed autoinjectors.
This week, the federal School Access to Emergency Epinephrine Law was enacted, which provides a financial incentive to states that require schools maintain a supply of the medication and permit trained school personnel to administer such medication in the form of preferences for receiving federal children’s asthma-treatment grants. The law also requires that the state attorney general review “any applicable civil liability protection law to determine the application of such law with regard to elementary and secondary school trained personnel who may administer epinephrine.”